1. 1517 Emergency department as place of end-of-life care and death in cancer patients. (September 2015) Authors: Pronzato, P.; Casabona, F.; Lambertini, M.; Morganti, S.; Reggiani, S.; Zoli, D.; Orengo, G. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab. (September 2015) Authors: Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P.; Del Mastro, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S286 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1957 Ovarian suppression with luteinizing hormone-releasing hormone agonists during chemotherapy as a strategy to preserve ovarian function and fertility in breast cancer patients: A systematic review and meta-analysis of randomized studies. (September 2015) Authors: Lambertini, M.; Ceppi, M.; Poggio, F.; Peccatori, F.A.; Azim, H.A.; Ugolini, D.; Pronzato, P.; Loibl, S.; Moore, H.C.F.; Partridge, A.H.; Del Mastro, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 24P The predictive and prognostic role of single nucleotide gene variants in PD-1 and PD-L1 in patients with advanced melanoma treated with PD-1 inhibitors. (December 2022) Authors: Boutros, A.; Carosio, R.; Campanella, D.; Spagnolo, F.; Banelli, B.; Morabito, A.; Pistillo, M.P.; Croce, E.; Cecchi, F.; Pronzato, P.; Queirolo, P.; Fontana, V.; Tanda, E.T. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 63P Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis. (December 2022) Authors: A. Boutros, ; Tanda, E.T.; Croce, E.; Catalano, F.; Ceppi, M.; Bruzzone, M.; Cecchi, F.; Arecco, L.; Fraguglia, M.; Pronzato, P.; Del Mastro, L.; Lambertini, M.; Spagnolo, F. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A12First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab. (26th September 2015) Authors: Vaglica, M.; Vaglica, M.; Lambertini, M.; Ferreira, A.; Poggio, F.; Puglisi, F.; Sottotetti, F.; Montemurro, F.; Poletto, E.; Pozzi, E.; Risi, E.; Lai, A.; Zanardi, E.; Sini, V.; Ziliani, S.; Minuti, G.; Mura, S.; Grasso, D.; Ferrarini, I.; Pronzato, P. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis. (June 2017) Authors: Poggio, F.; Ceppi, M.; Lambertini, M.; Bruzzi, P.; Ugolini, D.; Bighin, C.; Levaggi, A.; Giraudi, S.; D'Alonzo, A.; Vaglica, M.; Blondeaux, E.; Sertoli, M.R.; Pronzato, P.; Del Mastro, L. Journal: Breast Issue: Volume 33(2017) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HER2-positive metastatic breast cancer: A changing scenario. Issue 1 (July 2015) Authors: Mustacchi, G.; Biganzoli, L.; Pronzato, P.; Montemurro, F.; Dambrosio, M.; Minelli, M.; Molteni, L.; Scaltriti, L. Journal: Critical reviews in oncology/hematology Issue: Volume 95:Issue 1(2015) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Residual Risk of Relapse: a Systematic Review and a Consensus Project on Unmet needs for HER2-positive non Metastatic Breast Cancer Patients. (November 2022) Authors: Miglietta, F.; Pronzato, P.; Girardi, F.; Griguolo, G.; Guarneri, V.; Pappagallo, G.; Conte, P. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗